Joëlle Blumberg

Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors

Martyn Caplin, Marianne Pavel, Jarosław B. Ćwikła et al. · New England Journal of Medicine · 2014 · 1.9K citations · Full text

Treatment of the carcinoid syndrome with the longacting somatostatin analogue lanreotide: a prospective study in 39 patients.

Philippe Ruszniewski, Michel Ducreux, Jean‐Alain Chayvialle et al. · Gut · 1996 · 206 citations · Full text

The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumors

Michel Ducreux, Philippe Ruszniewski, Jean-Alain Chayvialle et al. · The American Journal of Gastroenterology · 2000 · 189 citations

Tumor Size, Pathology, Pharmacotherapy +16

Final Height after Long-Term Treatment with Triptorelin Slow Release for Central Precocious Puberty: Importance of Statural Growth after Interruption of Treatment

Jean‐Claude Carel, Marc Roger, S. Ispas et al. · The Journal of Clinical Endocrinology & Metabolism · 1999 · 170 citations

Evaluation of the Treatment of Thyrotropin-Secreting Pituitary Adenomas with a Slow Release Formulation of the Somatostatin Analog Lanreotide

Jean‐Marc Kuhn, S Arlot, Hervé Lefèbvre et al. · The Journal of Clinical Endocrinology & Metabolism · 2000 · 96 citations · Full text